+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Lymphoma Drugs Market Research Reports

From
Natural Killer T Cell Lymphoma - Pipeline Insight, 2021 - Product Thumbnail Image

Natural Killer T Cell Lymphoma - Pipeline Insight, 2021

  • Drug Pipelines
  • February 2021
  • 60 pages
From
Hodgkin's Lymphoma - Pipeline Insight, 2021 - Product Thumbnail Image

Hodgkin's Lymphoma - Pipeline Insight, 2021

  • Drug Pipelines
  • February 2021
  • 60 pages
From
From
From
From
From
From
From
Non-Hodgkin Lymphoma - Pipeline Review, H2 2020 - Product Thumbnail Image

Non-Hodgkin Lymphoma - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 3999 pages
From
Angioimmunoblastic T-cell lymphoma - Pipeline Insight, 2020 - Product Thumbnail Image

Angioimmunoblastic T-cell lymphoma - Pipeline Insight, 2020

  • Drug Pipelines
  • November 2020
  • 40 pages
From
Central Nervous System Lymphoma- Pipeline Insight, 2020 - Product Thumbnail Image

Central Nervous System Lymphoma- Pipeline Insight, 2020

  • Drug Pipelines
  • November 2020
  • 40 pages
From
T-Cell Lymphoma Market 2019-2025 - Product Thumbnail Image

T-Cell Lymphoma Market 2019-2025

  • Report
  • September 2020
From
From
Follicular Lymphoma - Pipeline Insight, 2020 - Product Thumbnail Image

Follicular Lymphoma - Pipeline Insight, 2020

  • Drug Pipelines
  • September 2020
  • 120 pages
From
From
Loading Indicator

Lymphoma encompasses a variety of blood cancers of the lymphatic system. Non-Hodgkin’s Lymphoma (NHL) for example, is diagnosed in over 100,000 every year in the US and EU combined. An array of expert reports in our Lymphoma Section enable you to investigate drug development strategies and market trends for NHL, Hodgkin’s Lymphoma, Skin Lymphoma, T-Cell Lymphoma, Indolent Lymphoma and other variants. Investigate key issues such as licensing, R&D, industry alliances, generic drugs (rituximab, bortezomib, doxorubicin, bleomycin, vinblastine, etc.) and the activities of major pharmaceutical players such as Bristol-Myers Squibb, GlaxoSmithKline, Hoffmann-La Roche, and Sanofi-Aventis. Show Less Read more

adroll